Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment‐resistant depression: A protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans

BACKGROUND: The breakthrough discovery has been made that a single dose of ketamine, an N‐methyl‐D‐aspartate receptor antagonist, achieves rapid and sustained (~7 days) antidepressant activity in patients with major depressive disorder (MDD). This discovery has ushered in an exciting era of research...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Chuanjun, Tian, Hongjun, Li, Gongying, Chen, Min, Jiang, Deguo, Lin, Xiaodong, Xu, Yong, Wang, Wenqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851815/
https://www.ncbi.nlm.nih.gov/pubmed/31617335
http://dx.doi.org/10.1002/brb3.1423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851815/
https://www.ncbi.nlm.nih.gov/pubmed/31617335
http://dx.doi.org/10.1002/brb3.1423

Ejemplares similares